Brachytherapy, a standard of care for some cancer indications, which involves delivering radiotherapy from a source within the tumour, is underfunded, increasingly marginalised and in decline across much of Europe. Janet Fricker talked to specialists [more]
After the European Medicines Agency (EMA) approves a new cancer drug, reimbursement decisions by each country’s health authorities can take up to one year, with wide variations between countries. according to a study just presented [more]
A professor of haematology, specialising in bone marrow transplants and leukaemia, with a career that has spanned clinical practice, research, policy making and now political office – Agnès Buzyn has an unrivalled breadth of experience [more]
When it comes to breast cancer screening with mammography, are women receiving a coherent message about the best age to start and to stop, and about frequency? A survey examined the situation in the United [more]